Physician profile
Willie D Epps
NPI 1902832504
$4,976.18
in general payments reported to CMS, 2019-2025
43 companies · $733 in 2025
The $733 reported for 2025 was more than what 80% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $680 · 2020: $704 · 2021: $1,033 · 2022: $525 · 2023: $656 · 2024: $646 · 2025: $733.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,014 · Education: $21.01.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,013.68 |
| Education | $21.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $772.78 | 2019-2025 | Rybelsus, Ozempic |
| Glaxosmithkline, LLC. | $461.77 | 2020-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Pfizer INC. | $452.91 | 2019-2025 | |
| Amgen INC. | $407.10 | 2021-2025 | Repatha, Otezla, Krystexxa |
| Lilly USA, LLC | $326.82 | 2019-2025 | Mounjaro, Zepbound, Trulicity |
| Insulet Corporation | $231.94 | 2021-2025 | Omnipod |
| Novartis Pharmaceuticals Corporation | $213.06 | 2019-2025 | |
| Mannkind Corporation | $212.52 | 2019-2022 | |
| Dexcom, INC. | $166.45 | 2021-2024 | Dexcom G6 Transmitter |
| Abbvie INC. | $162.29 | 2021-2022 | |
| Horizon Therapeutics Plc | $143.40 | 2019-2023 | Krystexxa |
| Antares Pharma, INC. | $124.47 | 2025 | Xyosted |
| Astellas Pharma US INC | $119.93 | 2019-2021 | |
| Viiv Healthcare Company | $112.38 | 2021-2025 | Cabenuva, Dovato |
| Lundbeck LLC | $107.85 | 2024-2025 | Rexulti |
Show all 43 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Willie Epps listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.